Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Cause-Specific Cardiovascular Death in Patients with CKD: A Meta-Analysis of CKD Progression Trials
Year: 2024
Type: review
Abstract: Clinical Trial registry name and registration number: ClinicalTrials.gov Identifiers: NCT02065791 (CREDENCE), NCT03036150 (DAPA-CKD), NCT03594110 (EMPA-KIDNEY).
Authors: Fletcher, Robert A, Herrington, William G, Agarwal, Rajiv, Mayne, Kaitlin J, Arnott, Clare, Jardine, Meg J, Mahaffey, Kenneth W, Perkovic, Vlado, Staplin, Natalie, Wheeler, David C, Chertow, Glenn M, Heerspink, Hiddo JL, Neuen, Brendon L
Institutions: UNSW Sydney, The George Institute for Global Health, Richard L. Roudebush VA Medical Center, Indiana University School of Medicine, The University of Sydney, National Health and Medical Research Council, Stanford Medicine, Stanford University, University College London, University Medical Center Groningen, University of Groningen, Royal North Shore Hospital
Language: English
Subfield: Nephrology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7075633506
FWCI:
Cites:
Cited by:
Related to: